Cargando…
Safety and efficacy of methylprednisolone versus dexamethasone in critically ill patients with COVID-19 acute respiratory distress syndrome: a retrospective study
BACKGROUND: Corticosteroids (CSs), specifically dexamethasone (DEX), are the treatment of choice for severe acute respiratory distress syndrome (ARDS) due to COVID-19 pneumonia (CARDS). However, data from both ARDS and relatively small CARDS clinical trials have suggested improved outcomes with meth...
Autores principales: | Kellogg, Dean, Gutierrez, G. Christina, Small, Clay E., Stephens, Benjamin, Sanchez, Paloma, Beg, Moezzullah, Keyt, Holly L., Restrepo, Marcos I., Attridge, Rebecca L., Maselli, Diego J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936170/ https://www.ncbi.nlm.nih.gov/pubmed/36818803 http://dx.doi.org/10.1177/20499361231153546 |
Ejemplares similares
-
Inhaled Antibiotic Therapy in Chronic Respiratory Diseases
por: Maselli, Diego J., et al.
Publicado: (2017) -
Dexamethasone/hydrocortisone/methylprednisolone: Disseminated cryptococcosis following off label use of dexamethasone, hydrocortisone and methylprednisolone: case report
Publicado: (2022) -
Prevention of ventilator-associated pneumonia in the intensive care unit: A review of the clinically relevant recent advancements
por: Keyt, Holly, et al.
Publicado: (2014) -
Skeletal Muscle Response to Deflazacort, Dexamethasone and Methylprednisolone
por: Fappi, Alan, et al.
Publicado: (2019) -
Dexamethasone/methylprednisolone/prednisolone: Psychosis: case report
Publicado: (2021)